Ayco Farms, Inc. has issued a formal clarification in response to recent media reports regarding its inclusion in the U.S. Food and Drug Administration’s (FDA) weekly Enforcement Report, emphasizing that there is no active recall and no affected product currently available in the marketplace.
The company explained that the listing referenced in the FDA report relates to a previously completed voluntary recall involving fresh whole cantaloupes. These products were distributed over a limited period, from December 12, 2025, through January 16, 2026, and were recalled earlier this year out of an abundance of caution due to the potential risk of Salmonella contamination. Importantly, Ayco Farms stressed that the recall was precautionary in nature and not the result of confirmed contamination in products reaching consumers.
According to the company, the recall process was initiated in close coordination with the FDA as part of standard food safety protocols. Voluntary recalls are a common and responsible measure within the food industry when there is even a minimal or unconfirmed risk to public health. In this case, Ayco Farms acted proactively to ensure consumer safety while maintaining transparency with regulatory authorities and its customers.
The recent attention surrounding the matter stems from the FDA’s routine reporting procedures. On March 24, 2026, Ayco Farms issued formal notifications to its customers, as agreed upon with the FDA. This notification marked a standard step in the recall documentation and reporting process, which ultimately triggered the inclusion of the case in the FDA’s Enforcement Report. The company underscored that such timing is procedural and does not indicate that affected products are still in circulation.
Ayco Farms further clarified that by the time the March notification was issued, all products associated with the recall had already exceeded their typical shelf life. Fresh cantaloupes generally have a refrigerated shelf life of approximately 30 days. Given the original distribution dates, any products tied to this recall would have naturally been removed from commerce well before the enforcement report was published. As a result, there has been no risk of exposure to consumers in recent weeks, and no recalled items remain available for purchase.
In addition to confirming the absence of affected products in the market, the company highlighted the results of extensive testing conducted throughout the recall process. All product samples, as well as environmental samples collected during internal reviews and by FDA investigators, tested negative for Salmonella Newport. These findings reinforce the precautionary nature of the recall and support the conclusion that there was no confirmed contamination impacting consumers.
Ayco Farms also noted that all directly affected customers were promptly and thoroughly notified as part of the formal recall procedure. The company worked closely with its distribution partners and clients to ensure that any potentially impacted shipments were identified and handled appropriately. This coordinated response reflects the company’s commitment to maintaining strong relationships with its partners while prioritizing safety and compliance.
The company emphasized that firms within the scope of the voluntary recall were contacted directly, ensuring clear communication and swift action across the supply chain. Such direct outreach is a critical component of effective recall management, helping to prevent confusion and ensure that all stakeholders are aligned in their response.
Ayco Farms reiterated that its inclusion in the FDA Enforcement Report should not be interpreted as an indication of ongoing risk or regulatory concern. Instead, it represents the final administrative step in a recall process that had already been completed in full accordance with FDA guidelines. The company expressed concern that recent media coverage may have mischaracterized the situation, potentially causing unnecessary alarm among consumers and partners.
Food safety remains a top priority for Ayco Farms, and the company continues to uphold rigorous standards across its operations. From cultivation and harvesting to distribution and quality assurance, Ayco Farms implements comprehensive safety protocols designed to minimize risks and ensure product integrity. The company also maintains ongoing collaboration with regulatory agencies to stay aligned with best practices and evolving industry standards.
Transparency is another cornerstone of Ayco Farms’ approach. By voluntarily initiating the recall and openly communicating with the FDA, customers, and the public, the company demonstrated its commitment to accountability and consumer trust. Even in cases where risks are only potential or unconfirmed, Ayco Farms prioritizes taking decisive action to protect public health.
Looking ahead, the company remains focused on continuous improvement in its food safety systems. This includes regular testing, monitoring, and evaluation of both products and production environments. By investing in these measures, Ayco Farms aims to further strengthen its ability to identify and address potential risks before they impact the market.
In conclusion, Ayco Farms has made it clear that there is no active recall related to the FDA Enforcement Report listing and that no affected products are currently in circulation. The situation referenced in the report pertains to a completed, precautionary recall from earlier in the year, with all associated products long past their shelf life and removed from commerce. With all tests returning negative results and all stakeholders properly notified, the company reaffirms its dedication to food safety, regulatory compliance, and transparent communication.
Source Link:https://www.businesswire.com/
